Effects of Flaxseed Supplementation in Metabolic Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
To evaluate the effects of flaxseed supplementation on fasting blood sugar, lipid profile and anthropocentric measurements in subjects with metabolic syndrome, in a randomized, open-labeled, controlled pilot study, 44 subjects with metabolic syndrome will be received 30g/d flaxseed with lifestyle modification or lifestyle modification alone for 12 weeks. Both groups will be advised to follow an energy balanced diet and physical activity recommendations. Parameters related to metabolic syndrome will be measured at the baseline and at the end of the study.
Epistemonikos ID: f86f981b9dea5e31ce82cd079dbae0a8f9f45b19
First added on: May 12, 2024